Recombinant Anti-CD22 x Anti-saporin Bispecific Antibody (scIgG) (SCIGG-053)

Recombinant Anti-CD22 x Anti-saporin Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD22 and anti-saporin IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can be used in pretargeting system and deliver immunotoxin to tumor cells. It is designed for the research of Lymphoma therapy.

Datasheet

Specifications

Targets

CD22 & saporin

Type

Single chain IgGs

Species Reactivity

Human

Target 1

CD22

Host Animal 1

Mouse

Target 2

saporin

Host Animal 2

Mouse

Application

FuncS; Pretargeting system for immunotoxin delivery

Related Disease

Lymphoma

Targets

Target 1

CD22

Gene ID

933

UniProt ID

P20273

Alternative Names

CD22; CD22 molecule; Cluster of differentiation 22; SIGLEC2; SIGLEC-2; B-cell receptor CD22; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; B-lymphocyte cell adhesion molecule; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2

Target 2

saporin

Alternative Names

Saporin; Ribosome inactivating protein; RIP

Our services and products are only for lab research, not for any diagnostic or therapeutic use.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY

Online Inquiry

USA
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Germany
Heidenkampsweg 58, 20097 Hamburg, Germany
Email:

UK
167-169 Great Portland Street, 5th Floor, London, W1W 5PE
Tel: 44-207-097-1828
Email: